Research and Markets: North American Pharmaceutical Market: Strategic Assessments of Leading Suppliers

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of the "North American Pharmaceutical Market: Strategic Assessments of Leading Suppliers" report to their offering.

This report provides industry executives with strategically significant competitor information and analysis of the leading players in the North American pharmaceutical market.

The report provides a worldwide strategic overview of the pharmaceutical market, including:

  • Sales forecast for major product segments: ethical, OTC, generics.
  • Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others.

In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.

The report's major objectives include:

  • To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the North American pharmaceutical market.
  • To help current suppliers realistically assess their financial, technological and marketing capabilities vis--vis the leading competitors.
  • To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.
  • To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

Contains 1,353 pages and 127 tables

For more information visit


Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   North America

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Professional Services  Other Professional Services



Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.